Current guidelines recommend the use of warfarin in the first 3 months after bioprosthetic valve replacement and suggest longterm anticoagulation only in patients with obvious risk factors for thrombosis. Despite at low risk of thromboembolism, we present a case of a 72-year-old male patient with infected thrombus at bioprosthetic aortic valve with distal arterial embolization after 3 years of replacement surgery. The incidence of asymptomatic bioprosthetic valve thrombosis (BPVT) may be higher than anticipated and active surveillance echocardiography is needed to early detect BPVT before leading to fatal complication.
INTRODUCTION
The overall rate of biprosthetic valve thrombosis (BPVT) is 0.03% per year [1] and late valve thrombosis of Mosaic porcine prosthesis is 0.1% to 0.3% per patient-year [2, 3] . It is a comparatively rare complication, but the sequelae may be fatal. For the antithrombotic therapy of bioprosthetic valve, the American College of Cardiology/ American Heart Association (ACC/AHA) guidelines [4] recommend the use of warfarin for at least 3 months and as long as 6 months after bioprosthetic aortic valve replacement (AVR) and suggest long-term anticoagulation only in patients with obvious risk factors for thrombosis as history of thromboembolism, hypercoagulable conditions, left ventricular dysfunction, and ongoing atrial fibrillation. Herein, we present a case of a 72-year-old male patient at a low risk of thromboembolism presenting an infected thrombus at bioprosthetic aortic valve (AV) with distal arterial embolization after 3 years of replacement surgery.
CASE REPORT
A 72-year-old man was admitted to Hallym Sacred Heart Hospital with poor oral intake, fever, and chills for 2 weeks. He had a history of hypertension and had undergone bioprosthetic AVR (23 mm Medtronic Mosaic porcine prosthesis) for degenerative AV stenosis 3 years ago. Postoperatively, the patient was anticoagluated with warfarin for 6 months and has taken aspirin until admission. Physical examination disclosed a grade of 2/6 systolic ejection murmur at the aortic area and a blood pressure of 150/90 mm Hg, heart rate 95 beats/min, and a temperature of 38.5°C. Electrocardiography showed sinus rhythm with right bundle branch block and chest radiography showed no cardiomegaly. Laboratory studies yielded the following results: white blood cell 19.6×10 ( Fig. 2A, B) . Overall, mobile mass at biprosthetic AV was identified as infected thrombus which caused distal arterial embolization.
Because he was hemodynamically stable, we began to anticoagulate with low molecular weight heparin and oral warfarin. (Fig. 3A, B) . To summarize, the patient received 2 weeks of valve dysfunction is suspected [4, 5] . However, the occurrence of BPVT in this patient at low risk for thromboembolism and the published cases diagnosed as BPVT on aspirin therapy in which the mean interval of BPVT was 13 months (range, 7 to 47 months)
after replacement surgery [6] [7] [8] [9] , suggest the true incidence of asymptomatic BPVT may be higher than anticipated and stress the necessity of routine annual echocardiography for the first 5 years of post replacement surgery.
The initial standard therapy for left-sided prosthetic valve thrombosis has been surgery or thrombolysis [4] . However, in hemodynamically stable patients, anticoagulation with vitamin K antagonist (VKA) could be a safe and effective treatment precluding re-do valve operation in patients with obstructive thrombosis at bioprosthetic AV [6, 9, 10] . In this case, although thrombus is 
